ATE477809T1 - Verwendung einer kombination von theanin und serotonin gegen schlafstörung - Google Patents

Verwendung einer kombination von theanin und serotonin gegen schlafstörung

Info

Publication number
ATE477809T1
ATE477809T1 AT05727560T AT05727560T ATE477809T1 AT E477809 T1 ATE477809 T1 AT E477809T1 AT 05727560 T AT05727560 T AT 05727560T AT 05727560 T AT05727560 T AT 05727560T AT E477809 T1 ATE477809 T1 AT E477809T1
Authority
AT
Austria
Prior art keywords
serotonin
theanine
combination
sleep disorder
sleep improvement
Prior art date
Application number
AT05727560T
Other languages
German (de)
English (en)
Inventor
Makoto Ozeki
Haruo Yao
Tsutomu Okubo
Lekh Raj Juneja
Original Assignee
Taiyokagaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyokagaku Co Ltd filed Critical Taiyokagaku Co Ltd
Application granted granted Critical
Publication of ATE477809T1 publication Critical patent/ATE477809T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT05727560T 2004-04-06 2005-04-01 Verwendung einer kombination von theanin und serotonin gegen schlafstörung ATE477809T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004111726 2004-04-06
PCT/JP2005/006468 WO2005097101A1 (ja) 2004-04-06 2005-04-01 睡眠改善用組成物

Publications (1)

Publication Number Publication Date
ATE477809T1 true ATE477809T1 (de) 2010-09-15

Family

ID=35124819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05727560T ATE477809T1 (de) 2004-04-06 2005-04-01 Verwendung einer kombination von theanin und serotonin gegen schlafstörung

Country Status (8)

Country Link
US (1) US8852656B2 (https=)
EP (1) EP1743633B1 (https=)
JP (1) JP4951162B2 (https=)
AT (1) ATE477809T1 (https=)
CA (1) CA2561616A1 (https=)
DE (1) DE602005023003D1 (https=)
TW (1) TW200539888A (https=)
WO (1) WO2005097101A1 (https=)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031309A (ja) * 2005-07-25 2007-02-08 Tokiwa Yakuhin Kogyo Kk 抗ストレス組成物
JP2006151987A (ja) * 2005-12-22 2006-06-15 Yasuo Chinen ビタミンｃとカルシウムによる睡眠剤
JP2009527504A (ja) 2006-02-23 2009-07-30 イオメディックス スリープ インターナショナル エスアールエル 良質な睡眠の誘導および維持のための組成物および方法
WO2007125883A1 (ja) * 2006-04-28 2007-11-08 Lion Corporation 睡眠改善用組成物
JP2008150352A (ja) * 2006-12-15 2008-07-03 Mg Seiyaku Kk 睡眠改善剤組成物
WO2008122102A1 (en) * 2007-04-05 2008-10-16 Iomedix Development International Srl Melatonin-based composition for improved sleep
US20080248106A1 (en) 2007-04-05 2008-10-09 Marvin Heuer Melatonin-based composition for improved sleep
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
BRPI0703312A2 (pt) * 2007-07-31 2009-03-17 Hanszmann Sandra Maria Salles composição e processo de fabricação de produto calmante e facilitador do sono
US20090155420A1 (en) * 2007-12-12 2009-06-18 Conopco, Inc., D/B/A Unilever Food product with stabilized non-protein amino acids
CN102137667A (zh) * 2008-09-01 2011-07-27 H.隆德贝克有限公司 包含加波沙朵和patl或oat抑制剂的药物组合物
WO2010065194A2 (en) * 2008-12-03 2010-06-10 Elc Management Llc Compositions and methods for promoting a relaxation state
RU2594876C2 (ru) * 2010-12-07 2016-08-20 Нестек С.А. Способы и композиции, предназначенные для улучшения сна у животных
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
BE1020005A5 (nl) * 2011-06-15 2013-03-05 Belgophar Bvba Samenstelling voor het behandelen van slaapstoornissen.
US20130064803A1 (en) * 2011-09-14 2013-03-14 Naidu Lp BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH
JP5989319B2 (ja) 2011-10-06 2016-09-07 ライオン株式会社 睡眠の質改善剤
KR20140082666A (ko) 2011-10-06 2014-07-02 라이온 가부시키가이샤 수면의 질 개선제
WO2013074531A1 (en) * 2011-11-14 2013-05-23 Requis Pharmaceuticals Inc. Combination nutritional and nutraceutical products
KR101296920B1 (ko) * 2013-01-21 2013-08-14 강영숙 숙면을 위한 마사지 오일
RU2013119044A (ru) * 2013-04-25 2014-10-27 Василий Васильевич Панкратов Средство для нормализации сна и биологических ритмов
US9895353B2 (en) 2013-09-11 2018-02-20 Zzeemag Inc. Use of L-tryptophan for the treatment of parasomnias
RU2697382C2 (ru) * 2014-05-04 2019-08-13 Фирмениш С.А. Ароматизированные продукты питания и напитки
WO2016057615A1 (en) * 2014-10-08 2016-04-14 Alva-Amco Pharmacal Companies, Inc. Composition for nap promotion
KR20250156824A (ko) * 2015-01-06 2025-11-03 데이비드 버톤 모바일 웨어러블 모니터링 시스템
ES2586632B1 (es) * 2015-01-29 2017-09-05 Wug Functional Gums, S.L Composición para elaborar chicles
CN104800774B (zh) * 2015-05-15 2018-05-18 成都市康飞药业有限公司 一种提高睡眠质量的组合物及其用途
WO2016195526A1 (ru) * 2015-06-03 2016-12-08 Людмила Борисовна ТИМИРОВА Успокаивающая композиция, понижающая возбудимость при половой охоте у кошек и собак
CN105963272A (zh) * 2016-03-16 2016-09-28 安徽珠峰生物科技有限公司 一种改善睡眠的保健胶囊
KR20190008265A (ko) 2016-05-06 2019-01-23 피지션즈 씰, 엘엘씨 발레리안 조성물 및 관련 방법
JP7037161B2 (ja) * 2016-07-07 2022-03-16 株式会社東洋新薬 経口組成物
US10806789B2 (en) * 2017-05-12 2020-10-20 The LIV Group Inc. Composition for enhanced absorption of supplements
US10369182B2 (en) * 2017-07-03 2019-08-06 Script Essentials, Llc Compositions and methods for treating insomnia and other sleep related disorders
WO2019145570A1 (en) 2018-01-29 2019-08-01 Alimentary Health Limited A combination product for prophylaxis and treatment of irritable bowel syndrome
US11771723B2 (en) 2018-01-29 2023-10-03 Precisionbiotics Group Limited Bifidobacterium longum NCIMB 41676
PL3777869T3 (pl) 2018-03-28 2024-12-16 Morinaga Milk Industry Co., Ltd. Kompozycja wspierająca sen oraz kompozycja lecznicza oraz kompozycja żywności i napoju wykorzystujące wspomnianą kompozycję wspierającą sen
CN108355088A (zh) * 2018-05-17 2018-08-03 河南夕阳蓝食品科技有限公司 一种改善睡眠质量的酸枣仁药酒及其制备方法
EP3868215A4 (en) * 2018-10-16 2022-07-27 Nippon Chemiphar Co., Ltd. SLEEP QUALITY IMPROVING AGENT
CN111053238A (zh) * 2019-12-30 2020-04-24 广州市中食科康保健食品有限公司 一种具有解压助眠作用的功能食品及其制备方法
AU2021217774A1 (en) * 2020-02-07 2022-06-16 Société des Produits Nestlé S.A. Sleep dietary supplement
US20230149330A1 (en) * 2020-04-14 2023-05-18 Nippon Chemiphar Co., Ltd. Sleep quality improver
WO2021222773A1 (en) * 2020-04-30 2021-11-04 MBI Distributing Compositions comprising n-acetyl methyl gaba and related methods
JP6863637B1 (ja) * 2020-07-01 2021-04-21 株式会社東洋新薬 睡眠改善用組成物
JP7548544B2 (ja) * 2020-07-06 2024-09-10 株式会社東洋新薬 睡眠改善用組成物
CN111671962B (zh) * 2020-07-21 2021-11-12 中香沉香产业发展(海南自贸区)有限公司 一种沉香熏香及制备方法
CN111820414A (zh) * 2020-08-03 2020-10-27 国珍健康科技（北京）有限公司 一种改善睡眠的保健食品及其制备方法
CN112205507A (zh) * 2020-09-30 2021-01-12 米宝有约(北京)医疗科技有限公司 一种能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用
CN112369492A (zh) * 2020-09-30 2021-02-19 广州普正生物科技有限公司 一种宁心安神改善睡眠的凝胶糖果及其制备方法
US20220347119A1 (en) * 2021-04-30 2022-11-03 Reshma N. Kheraj Medicated drink
US12213505B2 (en) 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same
KR102752488B1 (ko) * 2021-11-25 2025-01-10 이동현 수면의 질을 향상시킬 수 있는 기능성 건강식품 조성물
WO2023141688A1 (pt) * 2022-01-26 2023-08-03 Biolab Sanus Farmacêutica Ltda Composição farmacêutica veterinária
CN114949049A (zh) * 2022-02-22 2022-08-30 上海诺德生物实业有限公司 一种具有改善睡眠的茶氨酸和酸枣仁复合粉的配方
WO2025169217A1 (en) * 2024-02-08 2025-08-14 Council Of Scientific & Industrial Research A nutraceutical formulation for improving qualitative and quantitative sleep
CN118542458A (zh) * 2024-06-12 2024-08-27 云南雅微汝意投资有限公司 一种可安神助眠及改善记忆的复合功能性固体饮料
KR102949442B1 (ko) * 2025-09-16 2026-04-06 김민석 자몽향을 포함하는 혼합 음료 조성물 및 그 제조방법
CN120884641B (zh) * 2025-10-09 2026-02-27 湘湖实验室(农业浙江省实验室) 一种含藏红花的组合物及其在改善睡眠中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
JP3875733B2 (ja) 1994-12-16 2007-01-31 株式会社 伊藤園 体内アセトアルデヒド代謝促進剤及びその製造方法
CN1164422A (zh) * 1997-05-19 1997-11-12 北京三株工业有限责任公司 一种具有改善睡眠作用的功能食品
JP3038373B2 (ja) * 1997-10-29 2000-05-08 農林水産省 野菜・茶業試験場長 γ−アミノ酪酸含量の高い茶の製造法
CA2320368C (en) * 1998-02-23 2007-08-21 Taiyo Kagaku Co., Ltd. Composition comprising theanine
JP4653269B2 (ja) 1999-02-23 2011-03-16 太陽化学株式会社 テアニン含有組成物
JP2001086954A (ja) * 1999-09-20 2001-04-03 Yakult Honsha Co Ltd 健康飲食品
ATE419844T1 (de) * 2000-02-10 2009-01-15 Kao Corp Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems
KR20020089430A (ko) * 2000-04-05 2002-11-29 타이요 카가꾸 가부시키가이샤 수면촉진용 조성물
US20020122835A1 (en) * 2001-03-01 2002-09-05 Bucci Luke R. Compositions for enhancing muscle tissue recovery and repair
JP3519377B2 (ja) * 2001-04-06 2004-04-12 株式会社ヤクルト本社 ハーブ含有飲料
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
JP2003164259A (ja) * 2001-11-30 2003-06-10 Otsuka Yakuhin Kogyo Kk 抗酸化茶
JP2003183174A (ja) * 2001-12-19 2003-07-03 Fancl Corp 不眠症用組成物
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
JP3686063B2 (ja) * 2002-03-12 2005-08-24 末人 山上 睡眠障害の改善作用を有する健康補助食品
JP2003335691A (ja) * 2002-05-20 2003-11-25 Fancl Corp メラトニン関与疾患治療剤
JP3853254B2 (ja) 2002-05-22 2006-12-06 横浜ゴム株式会社 ポリエーテル系可塑剤およびその樹脂組成物

Also Published As

Publication number Publication date
EP1743633A1 (en) 2007-01-17
DE602005023003D1 (de) 2010-09-30
WO2005097101A1 (ja) 2005-10-20
EP1743633B1 (en) 2010-08-18
TWI364285B (https=) 2012-05-21
US8852656B2 (en) 2014-10-07
EP1743633A4 (en) 2007-05-16
CA2561616A1 (en) 2005-10-20
TW200539888A (en) 2005-12-16
JPWO2005097101A1 (ja) 2008-02-28
US20080044499A1 (en) 2008-02-21
JP4951162B2 (ja) 2012-06-13

Similar Documents

Publication Publication Date Title
ATE477809T1 (de) Verwendung einer kombination von theanin und serotonin gegen schlafstörung
DE602004031114D1 (de) Stickstoffhaltige heteroarylverbindungen und deren verwendungen zur erhoehung des gehaltes von endogenem erythropoietin
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
DK1347971T3 (da) Thiazolylinhibitorer af tyrosinkinaser fra Tec-familien
BRPI0413022A (pt) derivados de 3-amino cromado e 2-amino tetralina
CY1112590T1 (el) 3-[4-(ΔΙΒΕΝΖΟ[b,f][1,4]ΟΞΑΖΕΠΙΝ-11-ΥΛΟ)-ΠΙΠΕΡΑΖΙΝ-1-ΥΛΟ]-2,2-ΔΙΜΕΘΥΛΟ ΠΡΟΠΑΝΟΪΚΟ ΟΞΥ ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΙΑΤΑΡΑΧΩΝ ΤΟΥ ΥΠΝΟΥ
ATE227983T1 (de) Methoden zur verhütung von kristallwachstum und partikelaggregation in nanopartikelzusammensetzungen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
EA201100393A1 (ru) Применение усиливающих агентов, возможно связанных с рибофлавином, а также соответствующих офтальмологических композиций для перекрестного сшивания роговицы при лечении кератоконуса или других эктазийных расстройств роговицы
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
ID26033A (id) Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan
ATE461188T1 (de) Verstärker von glutamat-rezeptoren
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
DE602005018981D1 (de) Verfahren zur Herstellung von L-Cystein, und L-Cystein-produzierender Mikroorganismus
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
ATE416766T1 (de) Verfahren zur herstellung von 4-(2- dipropylaminoethyl)-1,3-dihydro-2h-indol-2-on- hydrochlorid
ATE419844T1 (de) Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems
WO2006135649A3 (en) Aminoquinoline and aminoquinazoline kinase modulators
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
DE602004025808D1 (de) Gaboxadol zur behandlung von depressionen und anderen affektiven störungen
DE60330921D1 (de) Verfahren zur Herstellung von modifiziertem Zinnoxidsol und Zinnoxid-Zirkonoxid-Mischsol.
DE60227576D1 (de) 3,6-DISUBSTITUIERTE AZABICYCLO i3.1.0 -HEXANDERIVATIVE ALS ANTAGONISTEN DES MUSCARINREZEPTORS
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
DK1397681T3 (da) Fremgangsmåde til identificering af midler til behandling af diabetes
ATE552251T1 (de) Thiophen- und furanverbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties